Grifols (GRFS) Exchange Rate Effect (2010 - 2021)
Grifols (GRFS) reported Exchange Rate Effect of $382.8 million for Q4 2021, up 217.82% on a YoY basis from $120.5 million in Q4 2020, and up 217.82% quarter-over-quarter from -$324.9 million in Q4 2020.
Grifols (GRFS) Exchange Rate Effect (2010 - 2021) Analysis & Trends
Grifols has reported Exchange Rate Effect for 12 years, with the latest figure at $382.8 million in Q4 2021.
- For the quarter ending Q4 2021, Exchange Rate Effect rose 217.82% year-over-year to $382.8 million; the trailing twelve-month figure through Dec 2021 stood at $382.8 million (up 217.82% YoY), and the FY2025 full-year result was -$109.4 million, down 565.44% from the prior year.
- Exchange Rate Effect for Q4 2021 stood at $382.8 million, up from -$324.9 million in the prior quarter.
- The five-year high for Exchange Rate Effect was $382.8 million in Q4 2021, with the low at -$324.9 million in Q4 2020.
- Historically, Exchange Rate Effect has averaged $23.0 million across 5 years, with a median of $15.1 million in 2020.
- Annual changes were most pronounced in 2018 — Exchange Rate Effect surged 432.43% — and 2020, when it plunged 665.8%.
- Grifols' Exchange Rate Effect stood at -$102.1 million in 2017, then jumped by 132.8% to $33.5 million in 2018, then surged by 71.52% to $57.4 million in 2019, then slumped by 665.8% to -$324.9 million in 2020, then soared by 217.82% to $382.8 million in 2021.
- The last three Exchange Rate Effect figures came in at $382.8 million (Q4 2021), -$324.9 million (Q4 2020), and $15.1 million (Q1 2020), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FX Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 93,699,046.73 Bn | 93,699,041.77 Bn | 7.76 Bn | 2.70 Mn |
| 2 | Eli Lilly | 1,012.06 Bn | 1,006.77 Bn | 16.22 Bn | 67.00 Mn |
| 3 | Johnson & Johnson | 560.67 Bn | 538.62 Bn | 15.96 Bn | -25.00 Mn |
| 4 | AbbVie | 402.20 Bn | 392.85 Bn | 10.78 Bn | -12.00 Mn |
| 5 | Merck | 298.59 Bn | 292.94 Bn | 12.09 Bn | -19.00 Mn |
| 6 | Amgen | 188.77 Bn | 176.74 Bn | 5.87 Bn | - |
| 7 | Gilead Sciences | 160.22 Bn | 152.49 Bn | 5.52 Bn | -11.00 Mn |
| 8 | Pfizer | 148.19 Bn | 135.42 Bn | -1.21 Bn | 19.00 Mn |
| 9 | Bristol Myers Squibb | 116.72 Bn | 106.26 Bn | 8.07 Bn | -48.00 Mn |
| 10 | Grifols | 6.05 Bn | 5.09 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 382.83 Mn |
| Dec 31, 2021 | 382.83 Mn |
| Dec 31, 2020 | -324.93 Mn |
| Dec 31, 2020 | -324.93 Mn |
| Mar 31, 2020 | 15.12 Mn |
| Mar 31, 2020 | 15.12 Mn |
| Dec 31, 2019 | 57.43 Mn |
| Dec 31, 2019 | 57.43 Mn |
| Mar 31, 2019 | 22.27 Mn |
| Mar 31, 2019 | 22.27 Mn |
| Dec 31, 2018 | 33.48 Mn |
| Dec 31, 2018 | 33.48 Mn |
| Jun 30, 2018 | 264.72 Mn |
| Jun 30, 2018 | 264.72 Mn |
| Mar 31, 2018 | -27.72 Mn |
| Mar 31, 2018 | -27.72 Mn |
| Dec 31, 2017 | -102.07 Mn |
| Dec 31, 2017 | -102.07 Mn |
| Jun 30, 2017 | -79.63 Mn |
| Jun 30, 2017 | -79.63 Mn |